# Ixabepilone and Pemetrexed/Solid Tumors

> **NCT01170871** · PHASE1 · WITHDRAWN · sponsor: **University of Southern California**

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Ixabepilone
- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT01170871
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrew support
- **Last updated:** 2014-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170871, "Ixabepilone and Pemetrexed/Solid Tumors". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01170871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*